Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Purdue Pharma L.P. et al v. Collegium Pharmaceutical, Inc.
Case Number:
1:17-cv-11923
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 16, 2018
Purdue's 'Duplicative' Suit Over OxyContin Generic Gets Ax
Tweaks to a generic opioid's labeling did not warrant OxyContin maker Purdue Pharma LP to file a separate lawsuit repeating extant patent infringement claims, a federal judge decided in a Boston court hearing Tuesday.
-
December 13, 2017
Purdue Loses Bid To Fuse Jumble Of OxyContin Patent Suits
Purdue Pharma LP lost an attempt on Wednesday to squeeze several oxycodone-related patent lawsuits into one trial in Massachusetts federal court, a minor setback in the manufacturer's claims seeking to guard the legal underpinnings of painkiller OxyContin.
-
October 06, 2017
Collegium Infringing OxyContin Patents, Purdue Says
Collegium Pharmaceutical Inc. is infringing two of Purdue Pharma LP's patents tied to the opioid painkiller OxyContin when making and selling its painkiller Xtampza ER, Purdue alleged on Friday in Massachusetts federal court, as part of a long line of similar suits.